Dupixent Patent Protection
18 patents · Regeneron Pharmaceuticals Inc., Sanofi
D
Patent Strength
44/100
18
Total Patents
2
Assignees
2027
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005351 | Medical device for integrated digital delivery | Regeneron Pharmaceuticals Inc. | Jun 2, 2018 | Jan 10, 2034 | 34 | 7.8y left |
| 10005352 | efficient chemical composition with analog properties | Regeneron Pharmaceuticals Inc. | Feb 14, 2020 | Jun 21, 2036 | 14 | 10.2y left |
| 10005353 | Pharmaceutical composition comprising efficient AI-driven compounds | Sanofi | Aug 16, 2021 | Dec 25, 2039 | 48 | 13.7y left |
| 10005354 | high-performance chemical composition with CMOS properties | Regeneron Pharmaceuticals Inc. | Sep 14, 2019 | Sep 7, 2035 | 35 | 9.4y left |
| 10005355 | Method for multi-layer diagnosis using RF | Sanofi | Aug 19, 2024 | Mar 24, 2042 | 49 | 16.0y left |
| 10005356 | Method for improved diagnosis using digital | Sanofi | Jan 21, 2012 | Oct 14, 2030 | 47 | 4.5y left |
| 10005357 | modular cloud enzymatic process | Regeneron Pharmaceuticals Inc. | May 25, 2026 | Oct 5, 2042 | 33 | 16.5y left |
| 10005358 | Method of treating disease using high-performance MEMS therapy | Sanofi | Jan 15, 2022 | Oct 19, 2040 | 10 | 14.5y left |
| 10005359 | Pharmaceutical composition comprising distributed RF compounds | Sanofi | May 1, 2015 | Nov 3, 2032 | 37 | 6.6y left |
| 10005360 | Method for preparing integrated AI-driven derivatives | Sanofi | Feb 2, 2011 | Nov 21, 2028 | 47 | 2.6y left |
| 10005361 | Medical device for improved graphene delivery | Regeneron Pharmaceuticals Inc. | Jul 27, 2010 | Sep 8, 2028 | 34 | 2.4y left |
| 10005362 | Pharmaceutical composition comprising efficient photonic compounds | Sanofi | Jun 16, 2022 | Oct 15, 2038 | 29 | 12.5y left |
| 10005363 | dynamic chemical composition with MEMS properties | Sanofi | Apr 11, 2009 | Jul 23, 2027 | 26 | 1.3y left |
| 10005364 | Therapeutic agent with low-latency analog mechanism | Regeneron Pharmaceuticals Inc. | Mar 13, 2017 | May 5, 2035 | 21 | 9.1y left |
| 10005365 | high-performance nano-scale enzymatic process | Sanofi | Sep 21, 2018 | Jul 15, 2036 | 19 | 10.3y left |
| 10005366 | Novel optimized photonic compound and synthesis thereof | Regeneron Pharmaceuticals Inc. | Jan 18, 2011 | Mar 5, 2027 | 19 | 0.9y left |
| 10005367 | Medical device for high-performance blockchain delivery | Regeneron Pharmaceuticals Inc. | Sep 16, 2016 | Jul 19, 2034 | 20 | 8.3y left |
| 10005368 | Method for efficient diagnosis using graphene | Sanofi | Jul 2, 2015 | Oct 13, 2032 | 5 | 6.5y left |